Paraneoplastisk polynevropati
Sist oppdatert: Sist revidert:
Sist revidert av:Åse Mygland
- Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol. 2017 Oct;30(5):513-52000000000475. PMID: . pmid:28682959 PubMed
- Jitprapaikulsan J, Klein CJ, Pittock SJ, Gadoth A, McKeon A, Mills JR, Dubey D. . Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG. J Neurol Neurosurg Psychiatry 2020. pmid:31801846 PubMed
- Zoccarato M, Grisold W, Grisold A, Poretto V, Boso F, Giometto B. Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria. Front Neurol. 2021 Oct 1;12:706169. PMID: 34659082 PubMed
- Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, Grisold W, Honnorat J, Sillevis Smitt PA, Tanasescu R, Vedeler CA, Voltz R, Verschuuren JJ; European Federation of Neurological Societies. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011; 18: 19-e3. PMID: 20880069 PubMed
- Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011. pmid:20880069 PubMed
- Graus F, Dalmau J. Paraneoplastic neuropathies. Curr Opin Neurol. 2013 Oct;26(5):489-95PMID: 23892629 PubMed
- Giometto B, Vitaliani R, Lindeck-Pozza E, Grisold W, Vedeler C. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 2012; 12: CD007625. doi:10.1002 The Cochrane Library
- Åse Mygland, spesialist i nevrologi, professor dr med
- Unn Ljøstad, spesialist i nevrologi, professor PhD
- Anette Storstein, spesialist i nevrologi PhD